APO Research
Talk to an analyst

APO RESEARCH · REPORT

Emphysema Drug

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Emphysema Drug Market Outlook and Growth Opportunities 2026

26 December 2025193 pages

Choose your research edition.

Industry ResearchEmphysema Drug Industry Research Report 2026117 pages · $2,950 USDIndustry Growth & TrendsGlobal Emphysema Drug Industry Growth and Trends Forecast to 203293 pages · $3,450 USDMarket StructureGlobal Emphysema Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032189 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Emphysema Drug Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Emphysema Drug Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

The global Emphysema Drug market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Emphysema Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Emphysema Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Emphysema Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Emphysema Drug market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Emphysema Drug market include Angion Biomedica Corp., ProMetic Life Sciences Inc., rEVO Biologics, Inc., SATT North SAS and TGV-Laboratories, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Emphysema Drug market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Emphysema Drug and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Emphysema Drug sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Emphysema Drug market size, projected growth trends, production technologies, key applications, and end-use industries.

Emphysema Drug Segment by Company

Angion Biomedica Corp.

ProMetic Life Sciences Inc.

rEVO Biologics, Inc.

SATT North SAS

TGV-Laboratories

Emphysema Drug Segment by Type

MG-53

EDO-66

BB-3

Others

Emphysema Drug Segment by Application

Hospital

Clinic

Others

Emphysema Drug Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Emphysema Drug status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Emphysema Drug market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Emphysema Drug significant trends, drivers, influence factors in global and regions.

6. To analyze Emphysema Drug competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Emphysema Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Emphysema Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Emphysema Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Emphysema Drug market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Emphysema Drug industry.

Chapter 3: Detailed analysis of Emphysema Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Emphysema Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Emphysema Drug in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Emphysema Drug Industry Trends Table 2. Emphysema Drug Industry Drivers Table 3. Emphysema Drug Industry Opportunities and Challenges Table 4. Emphysema Drug Industry Restraints Table 5. Global Emphysema Drug Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Emphysema Drug Revenue Share by Company (2021-2026) Table 7. Global Emphysema Drug Sales Volume by Company (W Units) & (2021-2026) Table 8. Global Emphysema Drug Sales Volume Share by Company (2021-2026) Table 9. Global Emphysema Drug Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Emphysema Drug Company Ranking, (2024-2026) & (USD Million) Table 11. Global Emphysema Drug Key Company Manufacturing Base & Headquarters Table 12. Global Emphysema Drug Company, Product Type & Application Table 13. Global Emphysema Drug Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Emphysema Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of MG-53 Table 18. Significant Companies of EDO-66 Table 19. Significant Companies of BB-3 Table 20. Significant Companies of Others Table 21. Global Emphysema Drug Sales Volume by Type 2021 VS 2025 VS 2032 (W Units) Table 22. Global Emphysema Drug Sales Volume by Type (2021-2026) & (W Units) Table 23. Global Emphysema Drug Sales Volume by Type (2027-2032) & (W Units) Table 24. Global Emphysema Drug Sales Volume Share by Type (2021-2026) Table 25. Global Emphysema Drug Sales Volume Share by Type (2027-2032) Table 26. Global Emphysema Drug Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Emphysema Drug Sales Value by Type (2021-2026) & (US$ Million) Table 28. Global Emphysema Drug Sales Value by Type (2027-2032) & (US$ Million) Table 29. Global Emphysema Drug Sales Value Share by Type (2021-2026) Table 30. Global Emphysema Drug Sales Value Share by Type (2027-2032) Table 31. Significant Companies of Hospital Table 32. Significant Companies of Clinic Table 33. Significant Companies of Others Table 34. Global Emphysema Drug Sales Volume by Application 2021 VS 2025 VS 2032 (W Units) Table 35. Global Emphysema Drug Sales Volume by Application (2021-2026) & (W Units) Table 36. Global Emphysema Drug Sales Volume by Application (2027-2032) & (W Units) Table 37. Global Emphysema Drug Sales Volume Share by Application (2021-2026) Table 38. Global Emphysema Drug Sales Volume Share by Application (2027-2032) Table 39. Global Emphysema Drug Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 40. Global Emphysema Drug Sales Value by Application (2021-2026) & (US$ Million) Table 41. Global Emphysema Drug Sales Value by Application (2027-2032) & (US$ Million) Table 42. Global Emphysema Drug Sales Value Share by Application (2021-2026) Table 43. Global Emphysema Drug Sales Value Share by Application (2027-2032) Table 44. Global Emphysema Drug Sales by Region: 2021 VS 2025 VS 2032 (W Units) Table 45. Global Emphysema Drug Sales by Region (2021-2026) & (W Units) Table 46. Global Emphysema Drug Sales Market Share by Region (2021-2026) Table 47. Global Emphysema Drug Sales by Region (2027-2032) & (W Units) Table 48. Global Emphysema Drug Sales Market Share by Region (2027-2032) Table 49. Global Emphysema Drug Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 50. Global Emphysema Drug Sales Value by Region (2021-2026) & (US$ Million) Table 51. Global Emphysema Drug Sales Value Share by Region (2021-2026) Table 52. Global Emphysema Drug Sales Value by Region (2027-2032) & (US$ Million) Table 53. Global Emphysema Drug Sales Value Share by Region (2027-2032) Table 54. Global Emphysema Drug Market Average Price (US$/Unit) by Region (2021-2026) Table 55. Global Emphysema Drug Market Average Price (US$/Unit) by Region (2027-2032) Table 56. Global Emphysema Drug Sales by Country: 2021 VS 2025 VS 2032 (W Units) Table 57. Global Emphysema Drug Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 58. Global Emphysema Drug Sales by Country (2021-2026) & (W Units) Table 59. Global Emphysema Drug Sales Market Share by Country (2021-2026) Table 60. Global Emphysema Drug Sales by Country (2027-2032) & (W Units) Table 61. Global Emphysema Drug Sales Market Share by Country (2027-2032) Table 62. Global Emphysema Drug Sales Value by Country (2021-2026) & (US$ Million) Table 63. Global Emphysema Drug Sales Value Market Share by Country (2021-2026) Table 64. Global Emphysema Drug Sales Value by Country (2027-2032) & (US$ Million) Table 65. Global Emphysema Drug Sales Value Market Share by Country (2027-2032) Table 66. Angion Biomedica Corp. Company Information Table 67. Angion Biomedica Corp. Business Overview Table 68. Angion Biomedica Corp. Emphysema Drug Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 69. Angion Biomedica Corp. Emphysema Drug Product Portfolio Table 70. Angion Biomedica Corp. Recent Development Table 71. ProMetic Life Sciences Inc. Company Information Table 72. ProMetic Life Sciences Inc. Business Overview Table 73. ProMetic Life Sciences Inc. Emphysema Drug Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. ProMetic Life Sciences Inc. Emphysema Drug Product Portfolio Table 75. ProMetic Life Sciences Inc. Recent Development Table 76. rEVO Biologics, Inc. Company Information Table 77. rEVO Biologics, Inc. Business Overview Table 78. rEVO Biologics, Inc. Emphysema Drug Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. rEVO Biologics, Inc. Emphysema Drug Product Portfolio Table 80. rEVO Biologics, Inc. Recent Development Table 81. SATT North SAS Company Information Table 82. SATT North SAS Business Overview Table 83. SATT North SAS Emphysema Drug Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. SATT North SAS Emphysema Drug Product Portfolio Table 85. SATT North SAS Recent Development Table 86. TGV-Laboratories Company Information Table 87. TGV-Laboratories Business Overview Table 88. TGV-Laboratories Emphysema Drug Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. TGV-Laboratories Emphysema Drug Product Portfolio Table 90. TGV-Laboratories Recent Development Table 91. Key Raw Materials Table 92. Raw Materials Key Suppliers Table 93. Emphysema Drug Distributors List Table 94. Emphysema Drug Customers List Table 95. Research Programs/Design for This Report Table 96. Authors List of This Report Table 97. Secondary Sources Table 98. Primary Sources List of Figures Figure 1. Emphysema Drug Product Image Figure 2. Global Emphysema Drug Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Emphysema Drug Sales Value (2021-2032) & (US$ Million) Figure 4. Global Emphysema Drug Sales (2021-2032) & (W Units) Figure 5. Global Emphysema Drug Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Emphysema Drug Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. MG-53 Image Figure 10. EDO-66 Image Figure 11. BB-3 Image Figure 12. Others Image Figure 13. Global Emphysema Drug Sales Volume by Type (2021 VS 2025 VS 2032) & (W Units) Figure 14. Global Emphysema Drug Sales Volume Share 2021 VS 2025 VS 2032 Figure 15. Global Emphysema Drug Sales Volume Share by Type (2021-2032) Figure 16. Global Emphysema Drug Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Emphysema Drug Sales Value Share 2021 VS 2025 VS 2032 Figure 18. Global Emphysema Drug Sales Value Share by Type (2021-2032) Figure 19. Hospital Image Figure 20. Clinic Image Figure 21. Others Image Figure 22. Global Emphysema Drug Sales Volume by Application (2021 VS 2025 VS 2032) & (W Units) Figure 23. Global Emphysema Drug Sales Volume Share 2021 VS 2025 VS 2032 Figure 24. Global Emphysema Drug Sales Volume Share by Application (2021-2032) Figure 25. Global Emphysema Drug Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 26. Global Emphysema Drug Sales Value Share 2021 VS 2025 VS 2032 Figure 27. Global Emphysema Drug Sales Value Share by Application (2021-2032) Figure 28. Global Emphysema Drug Sales by Region: 2021 VS 2025 VS 2032 (W Units) Figure 29. Global Emphysema Drug Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 30. Global Emphysema Drug Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 31. Global Emphysema Drug Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 32. North America Emphysema Drug Sales Value (2021-2032) & (US$ Million) Figure 33. North America Emphysema Drug Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Europe Emphysema Drug Sales Value (2021-2032) & (US$ Million) Figure 35. Europe Emphysema Drug Sales Value Share by Country (%), 2025 VS 2032 Figure 36. Asia-Pacific Emphysema Drug Sales Value (2021-2032) & (US$ Million) Figure 37. Asia-Pacific Emphysema Drug Sales Value Share by Country (%), 2025 VS 2032 Figure 38. South America Emphysema Drug Sales Value (2021-2032) & (US$ Million) Figure 39. South America Emphysema Drug Sales Value Share by Country (%), 2025 VS 2032 Figure 40. Middle East & Africa Emphysema Drug Sales Value (2021-2032) & (US$ Million) Figure 41. Middle East & Africa Emphysema Drug Sales Value Share by Country (%), 2025 VS 2032 Figure 42. USA Emphysema Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. USA Emphysema Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. USA Emphysema Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. Canada Emphysema Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. Canada Emphysema Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. Canada Emphysema Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Mexico Emphysema Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Mexico Emphysema Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Mexico Emphysema Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Germany Emphysema Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Germany Emphysema Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Germany Emphysema Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. France Emphysema Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. France Emphysema Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. France Emphysema Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. U.K. Emphysema Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. U.K. Emphysema Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. U.K. Emphysema Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Italy Emphysema Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Italy Emphysema Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Italy Emphysema Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Spain Emphysema Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Spain Emphysema Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Spain Emphysema Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Russia Emphysema Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Russia Emphysema Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Russia Emphysema Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Netherlands Emphysema Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Netherlands Emphysema Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Netherlands Emphysema Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. Nordic Countries Emphysema Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. Nordic Countries Emphysema Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. Nordic Countries Emphysema Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. China Emphysema Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. China Emphysema Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. China Emphysema Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Japan Emphysema Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Japan Emphysema Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Japan Emphysema Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. South Korea Emphysema Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. South Korea Emphysema Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. South Korea Emphysema Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. India Emphysema Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. India Emphysema Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. India Emphysema Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Australia Emphysema Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Australia Emphysema Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Australia Emphysema Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Southeast Asia Emphysema Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Southeast Asia Emphysema Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Southeast Asia Emphysema Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Brazil Emphysema Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Brazil Emphysema Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Brazil Emphysema Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Argentina Emphysema Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Argentina Emphysema Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Argentina Emphysema Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Chile Emphysema Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Chile Emphysema Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Chile Emphysema Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Colombia Emphysema Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Colombia Emphysema Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Colombia Emphysema Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Peru Emphysema Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Peru Emphysema Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Peru Emphysema Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Emphysema Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Saudi Arabia Emphysema Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Saudi Arabia Emphysema Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Israel Emphysema Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Israel Arabia Emphysema Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Israel Arabia Emphysema Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. UAE Emphysema Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. UAE Emphysema Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. UAE Emphysema Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Turkey Emphysema Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. Turkey Emphysema Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. Turkey Emphysema Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Iran Emphysema Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Iran Emphysema Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Iran Emphysema Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. Egypt Emphysema Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 124. Egypt Emphysema Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 125. Egypt Emphysema Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 126. Emphysema Drug Value Chain Figure 127. Manufacturing Cost Structure Figure 128. Emphysema Drug Sales Mode & Process Figure 129. Direct Comparison with Distribution Share Figure 130. Distributors Profiles Figure 131. Years Considered Figure 132. Research Process Figure 133. Key Executives Interviewed

Scope & coverage.

Types
  • MG-53
  • EDO-66
  • BB-3
  • Others
Applications
  • Hospital
  • Clinic
  • Others
Companies covered
  • Angion Biomedica Corp.
  • ProMetic Life Sciences Inc.
  • rEVO Biologics, Inc.
  • SATT North SAS
  • TGV-Laboratories

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Emphysema Drug Sales Value (2021-2032)
  4. 1.2.2 Global Emphysema Drug Sales Volume (2021-2032)
  5. 1.2.3 Global Emphysema Drug Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Emphysema Drug Market Dynamics
  1. 2.1 Emphysema Drug Industry Trends
  2. 2.2 Emphysema Drug Industry Drivers
  3. 2.3 Emphysema Drug Industry Opportunities and Challenges
  4. 2.4 Emphysema Drug Industry Restraints
3 Emphysema Drug Market by Company
  1. 3.1 Global Emphysema Drug Company Revenue Ranking in 2025
  2. 3.2 Global Emphysema Drug Revenue by Company (2021-2026)
  3. 3.3 Global Emphysema Drug Sales Volume by Company (2021-2026)
  4. 3.4 Global Emphysema Drug Average Price by Company (2021-2026)
  5. 3.5 Global Emphysema Drug Company Ranking (2024-2026)
  6. 3.6 Global Emphysema Drug Company Manufacturing Base and Headquarters
  7. 3.7 Global Emphysema Drug Company Product Type and Application
  8. 3.8 Global Emphysema Drug Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Emphysema Drug Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Emphysema Drug Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Emphysema Drug Market by Type
  1. 4.1 Emphysema Drug Type Introduction
  2. 4.1.1 MG-53
  3. 4.1.2 EDO-66
  4. 4.1.3 BB-3
  5. 4.1.4 Others
  6. 4.2 Global Emphysema Drug Sales Volume by Type
  7. 4.2.1 Global Emphysema Drug Sales Volume by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Emphysema Drug Sales Volume by Type (2021-2032)
  9. 4.2.3 Global Emphysema Drug Sales Volume Share by Type (2021-2032)
  10. 4.3 Global Emphysema Drug Sales Value by Type
  11. 4.3.1 Global Emphysema Drug Sales Value by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global Emphysema Drug Sales Value by Type (2021-2032)
  13. 4.3.3 Global Emphysema Drug Sales Value Share by Type (2021-2032)
5 Emphysema Drug Market by Application
  1. 5.1 Emphysema Drug Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.1.3 Others
  5. 5.2 Global Emphysema Drug Sales Volume by Application
  6. 5.2.1 Global Emphysema Drug Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Emphysema Drug Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Emphysema Drug Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Emphysema Drug Sales Value by Application
  10. 5.3.1 Global Emphysema Drug Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Emphysema Drug Sales Value by Application (2021-2032)
  12. 5.3.3 Global Emphysema Drug Sales Value Share by Application (2021-2032)
6 Emphysema Drug Regional Sales and Value Analysis
  1. 6.1 Global Emphysema Drug Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Emphysema Drug Sales by Region (2021-2032)
  3. 6.2.1 Global Emphysema Drug Sales by Region: 2021-2026
  4. 6.2.2 Global Emphysema Drug Sales by Region (2027-2032)
  5. 6.3 Global Emphysema Drug Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Emphysema Drug Sales Value by Region (2021-2032)
  7. 6.4.1 Global Emphysema Drug Sales Value by Region: 2021-2026
  8. 6.4.2 Global Emphysema Drug Sales Value by Region (2027-2032)
  9. 6.5 Global Emphysema Drug Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Emphysema Drug Sales Value (2021-2032)
  12. 6.6.2 North America Emphysema Drug Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Emphysema Drug Sales Value (2021-2032)
  15. 6.7.2 Europe Emphysema Drug Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Emphysema Drug Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Emphysema Drug Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Emphysema Drug Sales Value (2021-2032)
  21. 6.9.2 South America Emphysema Drug Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Emphysema Drug Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Emphysema Drug Sales Value Share by Country, 2025 VS 2032
7 Emphysema Drug Country-level Sales and Value Analysis
  1. 7.1 Global Emphysema Drug Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Emphysema Drug Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Emphysema Drug Sales by Country (2021-2032)
  4. 7.3.1 Global Emphysema Drug Sales by Country (2021-2026)
  5. 7.3.2 Global Emphysema Drug Sales by Country (2027-2032)
  6. 7.4 Global Emphysema Drug Sales Value by Country (2021-2032)
  7. 7.4.1 Global Emphysema Drug Sales Value by Country (2021-2026)
  8. 7.4.2 Global Emphysema Drug Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Emphysema Drug Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Emphysema Drug Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Emphysema Drug Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Emphysema Drug Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Emphysema Drug Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Emphysema Drug Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Emphysema Drug Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Emphysema Drug Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Emphysema Drug Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Emphysema Drug Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Emphysema Drug Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Emphysema Drug Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Emphysema Drug Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Emphysema Drug Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Emphysema Drug Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Emphysema Drug Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Emphysema Drug Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Emphysema Drug Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Emphysema Drug Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Emphysema Drug Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Emphysema Drug Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Emphysema Drug Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Emphysema Drug Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Emphysema Drug Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Emphysema Drug Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Emphysema Drug Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Emphysema Drug Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Emphysema Drug Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Emphysema Drug Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Emphysema Drug Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Emphysema Drug Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Emphysema Drug Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Emphysema Drug Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Emphysema Drug Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Emphysema Drug Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Emphysema Drug Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Emphysema Drug Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Emphysema Drug Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Emphysema Drug Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Emphysema Drug Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Emphysema Drug Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Emphysema Drug Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Emphysema Drug Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Emphysema Drug Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Emphysema Drug Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Emphysema Drug Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Emphysema Drug Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Emphysema Drug Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Emphysema Drug Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Emphysema Drug Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Emphysema Drug Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Emphysema Drug Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Emphysema Drug Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Emphysema Drug Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Emphysema Drug Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Emphysema Drug Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Emphysema Drug Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Emphysema Drug Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Emphysema Drug Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Emphysema Drug Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Emphysema Drug Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Emphysema Drug Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Emphysema Drug Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Emphysema Drug Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Emphysema Drug Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Emphysema Drug Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Emphysema Drug Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Emphysema Drug Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Emphysema Drug Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Emphysema Drug Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Emphysema Drug Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Emphysema Drug Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Emphysema Drug Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Emphysema Drug Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Emphysema Drug Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Emphysema Drug Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Emphysema Drug Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Emphysema Drug Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Emphysema Drug Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Emphysema Drug Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Emphysema Drug Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Emphysema Drug Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Emphysema Drug Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Emphysema Drug Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Angion Biomedica Corp.
  2. 8.1.1 Angion Biomedica Corp. Company Information
  3. 8.1.2 Angion Biomedica Corp. Business Overview
  4. 8.1.3 Angion Biomedica Corp. Emphysema Drug Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Angion Biomedica Corp. Emphysema Drug Product Portfolio
  6. 8.1.5 Angion Biomedica Corp. Recent Developments
  7. 8.2 ProMetic Life Sciences Inc.
  8. 8.2.1 ProMetic Life Sciences Inc. Company Information
  9. 8.2.2 ProMetic Life Sciences Inc. Business Overview
  10. 8.2.3 ProMetic Life Sciences Inc. Emphysema Drug Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 ProMetic Life Sciences Inc. Emphysema Drug Product Portfolio
  12. 8.2.5 ProMetic Life Sciences Inc. Recent Developments
  13. 8.3 rEVO Biologics, Inc.
  14. 8.3.1 rEVO Biologics, Inc. Company Information
  15. 8.3.2 rEVO Biologics, Inc. Business Overview
  16. 8.3.3 rEVO Biologics, Inc. Emphysema Drug Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 rEVO Biologics, Inc. Emphysema Drug Product Portfolio
  18. 8.3.5 rEVO Biologics, Inc. Recent Developments
  19. 8.4 SATT North SAS
  20. 8.4.1 SATT North SAS Company Information
  21. 8.4.2 SATT North SAS Business Overview
  22. 8.4.3 SATT North SAS Emphysema Drug Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 SATT North SAS Emphysema Drug Product Portfolio
  24. 8.4.5 SATT North SAS Recent Developments
  25. 8.5 TGV-Laboratories
  26. 8.5.1 TGV-Laboratories Company Information
  27. 8.5.2 TGV-Laboratories Business Overview
  28. 8.5.3 TGV-Laboratories Emphysema Drug Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 TGV-Laboratories Emphysema Drug Product Portfolio
  30. 8.5.5 TGV-Laboratories Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Emphysema Drug Value Chain Analysis
  2. 9.1.1 Emphysema Drug Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Emphysema Drug Sales Mode & Process
  6. 9.2 Emphysema Drug Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Emphysema Drug Distributors
  9. 9.2.3 Emphysema Drug Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst